Intraamygdaloid administration of BIBO 3304 increases water intake and extends anxiolytic effects

Polish Journal of Pharmacology

Volumn 56, Issue 6, 2004, Pages 867-870

  Wierońska, Joanna M ^a   Stachowicz, Katarzyna ^a   Kłodzińska, Aleksandra ^a   Śmiałowska, Maria ^a   Pilc, Andrzej ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

5 HTP; Amygdala; BIBO 3304; Water intake

Indexed keywords

5 HYDROXYTRYPTOPHAN; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR;

AMYGDALOID NUCLEUS; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ELECTRIC SHOCK; FLUID INTAKE; HYPOTHALAMUS; MALE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; TRANQUILIZING ACTIVITY;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; DRUG ADMINISTRATION ROUTES; MALE; RATS;

EID: 14244260287     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Eva C, Keinanen K, Monyer H, Seeburg P, Sprengel R: Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett, 1990, 271, 81-84.
2. Griebel G: Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? Pharmacol Ther, 1999, 82, 1-61.
3. Kask A, Rago L, Harro J: Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam. Eur J Pharmacol, 1996, 317, R3-R4.
4. Kask A, Vasar E, Heidmets LT, Allikmets L, Wikberg JE: Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat. Eur J Pharmacol, 2001, 414, 215-224.
5. Paxinos G, Watson C: The rat brain in stereotaxic co-ordinates. 2nd edn, Academic Press, San Diego, California, 92 101, 1986.
6. Rogóz Z, Skuza G, Kłodzińska A.: Anxiolyti-like effects of preferential dopamine D3 receptor agonists in an animal model. Pol J Pharmacol, 2003, 55, 449-454.
7. Rowland NE, Caputo FA, Fregly MJ: Water intake induced in rats by serotonin and 5-hydroxytryptophan: different mechanisms? Brain Res Bull, 1987, 18, 501-508.
8. Stanley BG, Chin AS, Leibowitz SF: Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action. Brain Res Bull, 1985, 14, 521-524.
9. Tatarczyńska E, Pałucha A, Szewczyk B, Chojnacka-Wójcik E, Wierońska J, Pilc A.: Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-amino-cyclopentane-1,3,4-tricarboxylic acid (ACPT-1) in rats. Pol J Pharmacol, 2002, 54, 707-710.
10. Vogel JR, Beer B, Clody DE: A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacology, 1971, 21, 1-7.